1. "Anesthesiology and Critical Care Medicine"
  2. "Jae Park"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (8)
  3. Review (1)
Groups
  1. Adult Leukemia (24)
  2. Anesthesiology and Critical Care Medicine (24)
  3. Center for Hematologic Malignancies (24)
  4. Critical Care Medicine (24)
  5. Department of Medicine (24)
  6. Hematologic Malignancies, Division of (24)

More Groups

People
  1. Elena Mead (24)
  2. Jae Park (24)
  3. Bianca Santomasso (21)
  4. Renier Brentjens (21)
  5. Elizabeth Halton (18)
  6. Claudia Diamonte (15)

More People

Years
  1. 2023 (3)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (6)
  5. 2019 (6)
  6. 2018 (4)

More Years

Publications
  1. Blood (6)
  2. Biology of Blood and Marrow Transplantation (4)
  3. Blood Advances (3)
  4. Journal of Clinical Oncology (2)
  5. New England Journal of Medicine (2)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Elsevier Inc. (5)
  3. American Society of Clinical Oncology (2)
  4. Massachusetts Medical Society (2)
  5. Nature Publishing Group (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients
    Journal Article

    Mahmood, S. S.; Riedell, P. A.; Feldman, S.; George, G.; Sansoterra, S. A.; Althaus, T.; Rehman, M.; Mead, E.; Liu, J. E.; Devereux, R. B.; more...
    European Heart Journal (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
    Meeting Abstract

    O'Cearbhaill, R. E.; Park, J. H.; Halton, E. F.; Diamonte, C. R.; Mead, E.; Lakhman, Y.; Kane, P.; Riviere, I. C.; Brentjens, R. J.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
    Journal Article

    Jain, T.; Knezevic, A.; Pennisi, M.; Chen, Y.; Ruiz, J. D.; Purdon, T. J.; Devlin, S. M.; Smith, M.; Shah, G. L.; Halton, E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery following chimeric antigen receptor T cell (CAR T) therapy in hematological malignancies
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; Mead, E.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save